Bitsch A - Search Results

1

Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?

Böttcher T, Rolfs A, Tanislav C, Bitsch A, Köhler W, Gaedeke J, Giese AK, Kolodny EH, Duning T. Böttcher T, et al. Among authors: bitsch a. PLoS One. 2013 Aug 28;8(8):e71894. doi: 10.1371/journal.pone.0071894. eCollection 2013. PLoS One. 2013. PMID: 24015197 Free PMC article.

2

Lesion development in Marburg's type of acute multiple sclerosis: from inflammation to demyelination.

Bitsch A, Wegener C, da Costa C, Bunkowski S, Reimers CD, Prange HW, Brück W. Bitsch A, et al. Mult Scler. 1999 Jun;5(3):138-46. doi: 10.1177/135245859900500302. Mult Scler. 1999. PMID: 10408713

3

A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions.

Bitsch A, Kuhlmann T, Stadelmann C, Lassmann H, Lucchinetti C, Brück W. Bitsch A, et al. Ann Neurol. 2001 Jun;49(6):793-6. doi: 10.1002/ana.1053. Ann Neurol. 2001. PMID: 11409432

4

Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange.

Keegan M, König F, McClelland R, Brück W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF. Keegan M, et al. Among authors: bitsch a. Lancet. 2005 Aug 13-19;366(9485):579-82. doi: 10.1016/S0140-6736(05)67102-4. Lancet. 2005. PMID: 16099294

5

Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production.

Braun N, Michel U, Ernst BP, Metzner R, Bitsch A, Weber F, Rieckmann P. Braun N, et al. Among authors: bitsch a. Neurosci Lett. 1996 Sep 6;215(2):75-8. Neurosci Lett. 1996. PMID: 8887999

6

The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions.

Werner K, Bitsch A, Bunkowski S, Hemmerlein B, Brück W. Werner K, et al. Among authors: bitsch a. Glia. 2002 Oct;40(1):121-9. doi: 10.1002/glia.10120. Glia. 2002. PMID: 12237849

7

Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis.

Dressel A, Kolb AK, Elitok E, Bitsch A, Bogumil T, Kitze B, Tumani H, Weber F. Dressel A, et al. Among authors: bitsch a. Acta Neurol Scand. 2006 Dec;114(6):368-73. doi: 10.1111/j.1600-0404.2006.00700.x. Acta Neurol Scand. 2006. PMID: 17083335 Clinical Trial.

8

Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.

Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Brück W. Kuhlmann T, et al. Among authors: bitsch a. Brain. 2002 Oct;125(Pt 10):2202-12. doi: 10.1093/brain/awf235. Brain. 2002. PMID: 12244078

9

Identification of macrophage populations expressing tumor necrosis factor-alpha mRNA in acute multiple sclerosis.

Bitsch A, da Costa C, Bunkowski S, Weber F, Rieckmann P, Brück W. Bitsch A, et al. Acta Neuropathol. 1998 Apr;95(4):373-7. doi: 10.1007/s004010050813. Acta Neuropathol. 1998. PMID: 9560015

10

Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.

Kuhlmann T, Lucchinetti C, Zettl UK, Bitsch A, Lassmann H, Brück W. Kuhlmann T, et al. Among authors: bitsch a. Glia. 1999 Oct;28(1):34-9. Glia. 1999. PMID: 10498820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters